US FDA reverses NDA nod for Sun Pharma’s anti epileptic drug
SPARC had earlier received a final approval from US FDA in March 2015 for this product
Sun Pharma Advanced Research Company…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Ajanta Pharma to replace Aditya Birla Nuvo on Nifty
The inclusion will take effect from October 19 this year
Ajanta Pharmaceuticals will be included in the NSE's Nifty Midcap 50…
Gary C Baughman appointed COO of M+W Americas
He will be responsible for the daily operations of M+W Americas and will oversee the functional groups of design, construction,…
US FDA approves Bionomics’ cancer drug
The drug targets hard-to-treat colorectal and pancreatic cancers, but may also prove suitable to treat breast, lung and other…
Pharmexcil organises Pharma CEOs Conclave
The theme of the conclave was 'Present Global Challenges — Preparedness of Industry'
DoP seeks foolproof system to curb ADRs
India should see that its drugs manufacturing and exports registers a manifold increase with no suspicion in their content and…
Department of Pharmaceuticals’ revamped website launched
The website is compliant with the guidelines issued by the Department of Administrative Reforms and Public Grievances
Piramal encourages pharma to embrace green chemistry ahead of CPhI
Processes improvements for original patented products need to be considered, as do improvements beyond even DMF and ANDA…
Promethera Biosciences appoints John Tchelingerian as CEO
Tchelingerian will focus on appropriate strategic decisions for the development and success of the company
Novartis launches access programme for 15 medicines
Novartis Access to be launched first in Kenya, Ethiopia and Vietnam
Novartis has launched Novartis Access, a portfolio of 15…